You are here : Home > Liten > Our start ups > Sublimed

Transcutaneous neurostimulation patch

Sublimed

Published on 26 July 2016

Sublimed aims to transform the lives of patients who live with chronic pain via a flexible, discreet, transcutaneous, neuro-stimulation patch. Commercialisation of the product is scheduled in 2016.

Transcutaneous neurostimulation has been used for over 30 years in the treatment of chronic pain, most notably for neuralgic and back pain. However, the generator/cables needed for this treatment are cumbersome and impractical meaning that 20-40% of patients reject the treatment.

Sublimed replaces traditional equipment with technological solutions based on 5 CEA patents:

  • A thin/flexible generator, with 20 hours of electrical autonomy, which can be placed anywhere on the body
  • Electrodes that can be easily placed on the body and that are connected by only 10-15cm of cable.
  •  “Command and control” functionality via the users smartphone, which can also transmit medical data to a doctor/medical practitioner.


These technological advances should help the adoption of such treatment as well as optimize its efficiency. The pain treatment centre of Grenoble University Hospital and leading pain specialists are involved in the development of this project.

Download data sheet here



Contact : nicolas.karst@cea.fr
simon.perraud@cea.fr

​Transcutaneous neurostimulation has been used for over 30 years in the treatment of chronic pain, most notably for neuralgic and back pain. However, the generator/cables needed for this treatment are cumbersome and impractical meaning that 20-40% of patients reject the treatment.